AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

ADAM SEGAL is the Ira A. Lipman Chair in Emerging Technologies and National Security and Director of the Digital and ...

British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC ...

That number falls short of Nvidia’s over 1 million China-specific H20 chips produced in the last nine months of 2024, ...

Across all industries, roles that ‘collate AI with human expertise’ are in demand and command a premium, report says.

China attaches great importance to the development of AI and is advancing its integration into the real economy. Through the "AI Plus" initiative, China is driving the intelligent transformation of ...

Global demand for lithium is rapidly increasing due to the growth of electric vehicles, with current recycling rates of ...

Alexandr Wang dropped out of MIT to co-found Scale and was quickly lauded as one of Silicon Valley's most promising ...

The report noted that their responsibilities entail training AI in literary and artistic expression, enhancing the system's ...

From generative AI to autonomous vehicles, European tech startups are breaking new ground — and grappling with the challenges ...

Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.

NVIDIA expands across Europe with major AI infrastructure deals, focusing on sovereign AI to offset China losses and boost ...